Nobutoshi Esaki

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injury.

Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injury.

Journal: Scientific reports
Published: February 21, 2026

Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer.

Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer.

Journal: The American journal of pathology
Published: July 23, 2025

Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

Journal: Nature communications
Published: May 28, 2025

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Journal: Oncogene
Published: March 31, 2025

Meflin/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression.

Meflin/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression.

Journal: Brain pathology (Zurich, Switzerland)
Published: March 26, 2025

Meflin confers antifibrotic properties to intestinal fibroblasts in inflammatory bowel disease.

Meflin confers antifibrotic properties to intestinal fibroblasts in inflammatory bowel disease.

Journal: The Journal of clinical investigation
Published: February 25, 2025

Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue.

Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue.

Journal: Pathology international
Published: November 02, 2024

Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis.

Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: May 07, 2024

Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

Journal: British journal of cancer
Published: November 29, 2023

Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.

Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.

Journal: The Journal of pathology
Published: January 24, 2023

Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.

Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.

Journal: Pathology, research and practice
Published: January 16, 2023

Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics.

Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics.

Journal: Oncogene
Published: May 04, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026